Endeavour program - CIMT

3rd CIMT Endeavour Workshop
May 12, 2015 from 07:30 – 12:00
Rheingoldhalle Congress Center Mainz
Rheinstraße 66, 55116 Mainz | Germany
CIMT Endeavour 2015 Program
07:30 – 08:00 Registration / Welcome Snack
08:00– 08:10 Welcome
Dr. Björn-Philipp Kloke, CIMT
08:10 – 09:20 Session 1: From Science to Products – Change of Perspectives
Chair: Dr. Harpreet Singh, immatics
CIMT-Scientist Presentation:
10 min + 25 min
Prof. Richard Kroczek, Robert Koch-Institut
„I nduction of massive antigen-specific CD8+ T cell cytotoxicity by targeting of antigen into XCR1+
DC combined with potent amplification regimes“
10 min + 25 min
Dr. Sebastian Kobold, Klinikum der Ludwig-Maximilians-Universität
Expert Advice Panel:
Discussion of abstracts
Dr. Ute Fink, Project Manager, Project Management Jülich
Dr. Thomas Hanke, Head of Immunology and Inflammation, Evotec
Michael Kring, Managing Director, High Tech Corporate Services GmbH
Dr. Ioannis Sapountzis, Global Head of Oncology Business Development
& Licensing, Boehringer Ingelheim GmbH
Dr. Rainer Wessel, Director, Ci3 Cluster
„A new fusion receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy“
09:20 – 09:50 Coffee break
09:50 – 10:40 Session 2: Company Story/Successful Deals
Chair: Dr. Jutta Heix, Oslo Cancer Cluster
20 min + 5 min
20 min + 5 min
Dr. Øyvind Arnesen, CEO, Ultimovacs AS
Prof. Dr. Dolores J. Schendel, CSO, Medigene AG
10:40– 11:00 Coffee break
11:00 – 11:45 Session 3: What Entrepreneurs in Europe Face
Chair: Dr. Cedrik M. Britten, GSK
40 min + 5 min
Key Note
Dr. Claus Kremoser, Managing Director, Phenex Pharmaceuticals AG
11:45 – 12:00 Closing Words
Dr. Cedrik M. Britten, CIMT
Sponsored by the:
In cooperation with: